Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Holger Schmidt
Brigham Young University, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Fluxus, Inc.
Other : Ownership of (b)(4) in Fluxus((b)(4)) and Consultant to Fluxus ((b)(4))
Dr. Holger Schmidt reports an annual conflict of interest for his PHS-funded project "Multiplexed, Non-Amplified, Nucleic Acid-Based Identification Of Multidrug Resistant Pathogens Using An Integrated Optofluidic Platform".
Schmidt explains that the proposed project aims to develop an optofluidic platform for detecting drug resistant
bacterial DNA at ultralow concentrations.
According to Schmidt, Fluxus Inc aims to develop optofluidic devices for diagnostic purposes, in particular protein
biomarkers. He explains that if the project is successful in demonstrating the capabilities of optofluidic devices, the
entity may be interested in using this approach for commercial purposes. Schmidt also asserts that the current target
area of the entity is protein biomarker detection, not detection of bacterial nucleic acids as is the goal of this PHS
project.
Schmidt reports owning stocks in the entity with a value of (b)(4), representing an estimated (b)(4) of the company. Additionally, he makes an income of (b)(4) working as a consultant for the entity, which has changed since last
year's disclosure. In this work, Schmidt advises the entity on the best path towards commercialization of their
technology. Schmidt reports no other payments from the entity. However, this project leverages a patent on multi
mode interference wave guides for multiplex optical detection that Dr. Schmidt co-invented and patented through
UCSC (The Regents of the University of California hold ownership of the IP). The entity holds rights to a pending
application/ license right from the University.
It is reasonable to anticipate that the entity could be affected by the research project, since the entity uses optofluidic approaches for their products, and they may be interested in licensing any new optofluidic approaches that would be patented as part of this project.
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform
The rising prevalence of antibiotic resistance in bacteria is a significant threat to public health. Infections with these bacteria are particularly dangerous because patients often die before they receive effective treatment. Current methods used to diagnose the cause and determine effective treatment strategies for bacterial infections of the blood are slow, and the infection often worsens while doctors wait for results. There is an urgent need for tests that will identify the bacteria causing a serious infection and the antibiotics to which these bacteria are resistant, and do so within 1 hour. This project describes the development of such a test.
Filed on June 18, 2019.
Tell us what you know about Holger Schmidt's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.